CMS delays Part D GLP-1 model amid skepticism from insurers
fiercehealthcare - The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers.
AI Summary: Federal regulators have paused a Medicare Part D pilot to expand coverage for GLP‑1 weight‑loss drugs amid payer skepticism and implementation concerns. The delay reflects worries about cost, program design and insurer buy‑in, forcing policymakers to revisit the model while patients and providers wait for clarity on whether Medicare will shoulder these high‑price therapies.
- CMS pauses Medicare GLP‑1 BALANCE pilot amid insurer pushback (4)
- Researchers chase GLP‑1 benefits, from gene therapy to Alzheimer’s (6)
- Telehealth and clinics scale GLP‑1 access, delivery and monitoring (3)
- All Other Stories
CMS pauses Medicare GLP‑1 BALANCE pilot amid insurer pushback
Researchers chase GLP‑1 benefits, from gene therapy to Alzheimer’s
Telehealth and clinics scale GLP‑1 access, delivery and monitoring
All Other Stories
UK passes bill that will eventually ban cigarette purchases
abcnews - Parliament has passed a bill to make cigarettes inaccessible to future generations in the U.K. Children born after December 31, 2008, will never be able to buy cigarettes under the new Tobacco and Vapes Bill
AI Summary: The UK has passed legislation phasing out tobacco sales for younger generations, effectively banning cigarette purchases for people born after 2008. The law creates a rolling age‑based prohibition aimed at cutting smoking initiation and long‑term health harms, while stirring debate over enforcement, retail impact and the practicalities of turning childhood prevention into adult policy.
- Explainers and advocacy for the Tobacco and Vapes Bill (4)
- Health context: cancer burden and treatment equity (3)
- Parliament approves smoking ban for future generations (4)
- All Other Stories